Bladder Cancer Flashcards

1
Q

What is bladder cancer, and which type is most common?

A

Bladder cancer is a malignancy of the epithelial lining of the urinary bladder. The most common type is transitional cell carcinoma (TCC).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who is most likely to be affected by bladder cancer, and how does the incidence change with age?

A

Bladder cancer is more prevalent in men than in women, and its incidence increases with age, with the majority of cases diagnosed in individuals over 55 years old.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the hallmark symptom of bladder cancer?

A

The hallmark symptom of bladder cancer is hematuria, which can be either gross (visible) or microscopic (detected on urine analysis).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are other common symptoms of bladder cancer?

A

Other symptoms may include dysuria (painful urination), frequency (increased need to urinate), urgency (strong need to urinate), and lower abdominal pain (associated with more advanced disease).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is painless hematuria significant in bladder cancer diagnosis?

A

Painless hematuria, especially in early-stage disease, is a common presenting symptom of bladder cancer, making it crucial for early detection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What other conditions can cause hematuria, and how does this relate to bladder cancer?

A

Hematuria can also result from urinary tract infections (UTIs), kidney stones, prostate disease, trauma, or bladder infections (cystitis). However, unexplained hematuria, particularly in at-risk populations, raises concern for bladder cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What should be done when a patient presents with hematuria?

A

Any patient presenting with hematuria should be evaluated for bladder cancer, especially older individuals or those with risk factors, while also ruling out other differential diagnoses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the key steps in the investigation of hematuria?

A

The key steps are:

  1. History and physical examination
  2. Urine dipstick and microscopy
  3. Urinary cytology
  4. Imaging studies (ultrasound, CT urography, MRI)
  5. Cystoscopy
  6. Biopsy (if a tumor is visualized)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is involved in the history and physical examination for hematuria investigation?

A

The history includes assessing risk factors like smoking, occupational exposure, and chronic bladder infections. The physical examination involves palpation of the abdomen and pelvic area to detect signs of advanced disease, such as a palpable bladder mass.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What role do urine dipstick and microscopy play in investigating hematuria?

A

Urine dipstick tests for blood, followed by microscopic analysis to assess the number of red blood cells (RBCs) and detect abnormal cells. Microscopic hematuria (more than 3 RBCs per high-power field) is significant and requires further investigation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is urinary cytology, and when is it used in bladder cancer investigation?

A

Urinary cytology examines a urine sample for cancerous cells. It is particularly useful in detecting high-grade bladder cancer. However, it has high specificity but lower sensitivity, especially for low-grade tumors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What imaging studies are used in the investigation of hematuria?

A

Ultrasound: Often the first modality to rule out causes like kidney stones or urinary tract obstruction.

CT Urography (CTU): Provides a detailed assessment of the urinary tract and can detect masses and urothelial abnormalities. It is more sensitive than ultrasound.

MRI: Used for staging in advanced cases, especially for assessing pelvic and extravesical spread.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is cystoscopy, and why is it important in the investigation of hematuria?

A

Cystoscopy is the gold standard for diagnosing bladder cancer. It allows direct visualization of the bladder to detect tumors, inflammation, or other abnormalities. It is performed under local anesthesia and is essential for obtaining biopsy specimens for histopathological evaluation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the role of biopsy in the investigation of bladder cancer?

A

If a tumor is visualized during cystoscopy, a biopsy is performed to confirm the diagnosis and determine the grade and stage of the tumor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is smoking related to bladder cancer?

A

Smoking is the most important risk factor for bladder cancer. Tobacco smoke contains carcinogens that are excreted in the urine, where they can damage the bladder lining and increase the risk of cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What occupational exposures increase the risk of bladder cancer?

A

Exposure to industrial chemicals, particularly aromatic amines (e.g., from dyes and rubber manufacturing), is a known risk factor for bladder cancer.

17
Q

How do chronic bladder infections contribute to bladder cancer risk?

A

Long-term bladder inflammation or chronic infections can increase the risk of bladder cancer by causing continuous damage to the bladder lining.

18
Q

How does a history of previous cancers affect the risk of bladder cancer?

A

A history of other cancers, such as colorectal cancer or prostate cancer, can increase the likelihood of developing bladder cancer.

19
Q

What is the connection between schistosomiasis and bladder cancer?

A

Schistosomiasis, a parasitic infection, is associated with an increased risk of squamous cell carcinoma of the bladder, particularly in endemic areas such as parts of Africa and the Middle East.

20
Q

How do age and gender influence the risk of bladder cancer?

A

The risk of bladder cancer increases with age, and men are more commonly affected than women.

21
Q

How does family history impact the risk of bladder cancer?

A

A family history of bladder cancer increases the likelihood of developing the disease, suggesting a genetic predisposition.

22
Q

How is bladder cancer staged?

A

Bladder cancer is staged according to the TNM system:

T: Depth of invasion into the bladder wall.
N: Involvement of regional lymph nodes.
M: Presence of metastasis to distant organs.

23
Q

What are the characteristics of Non-Muscle Invasive Bladder Cancer (NMIBC)?

A

NMIBC is confined to the mucosa or submucosa. It includes:

Ta: Non-invasive papillary carcinoma.
T1: Tumor invades the submucosa but not the muscle layer.

24
Q

What are the stages of Muscle-Invasive Bladder Cancer (MIBC)?

A

MIBC involves deeper layers of the bladder wall:

T2: Tumor invades the muscle layer.
T3: Tumor extends through the bladder wall into surrounding tissues.
T4: Tumor invades nearby structures (e.g., prostate, uterus).

25
How is the grade of bladder cancer determined?
The grade refers to how abnormal the cancer cells appear and their likelihood of growing and spreading. The WHO/ISUP grading system includes: Low Grade: Cells resemble normal cells, grow slowly, and are less likely to spread. High Grade: Cells appear abnormal, grow quickly, and have a higher risk of spreading.
26
What is the treatment for low-grade and high-grade NMIBC?
Low-grade Ta: Treated with transurethral resection of bladder tumor (TURBT) and often followed by intravesical chemotherapy (e.g., mitomycin C) or Bacillus Calmette–Guérin (BCG) immunotherapy to reduce recurrence. High-grade Ta or T1: TURBT followed by intravesical BCG therapy, which is the standard treatment for high-risk NMIBC and helps reduce recurrence and progression.
27
What is the treatment for muscle-invasive bladder cancer (MIBC)?
T2 and beyond: Often involves radical cystectomy (removal of the bladder) if the patient is fit for surgery. Chemotherapy (e.g., gemcitabine and cisplatin) is used before or after surgery to improve outcomes. For non-surgical candidates, chemoradiotherapy may be an option
28
How is metastatic bladder cancer treated?
Treatment for metastatic bladder cancer typically involves: Chemotherapy: Cisplatin-based regimens. Immunotherapy: PD-1 inhibitors (e.g., pembrolizumab) for advanced or metastatic disease.
29
What is the first-line procedure for diagnosing and treating superficial bladder tumors?
Transurethral resection of bladder tumor (TURBT) is the first-line procedure for diagnosing and treating superficial bladder tumors. It involves resecting the tumor through the urethra using a cystoscope.
30
What therapies are used for instillation after TURBT?
Intravesical chemotherapy (e.g., mitomycin C): Used following TURBT for low-risk cases and to prevent recurrence. BCG therapy: Used for high-risk cases, especially for high-grade tumors or T1 tumors.
31
What surgical options are available for bladder cancer?
Radical cystectomy: Considered for muscle-invasive or high-risk cases. It involves the removal of the bladder, prostate (in men), uterus, and ovaries (in women), as well as regional lymph node dissection. Urinary diversion: After cystectomy, the patient may need a new way to pass urine, such as: - Ileal conduit - Neobladder - Continent diversion
32
What are the key points in the management of bladder cancer?
Bladder cancer is common in older individuals. Early recognition through clinical symptoms like hematuria and a thorough diagnostic workup (cystoscopy, cytology, imaging) is crucial. Treatment depends on the stage and grade of the cancer: - Non-muscle invasive cases: Managed with endoscopic resection and intravesical therapies. - Muscle-invasive and metastatic cases: Managed with radical cystectomy, chemotherapy, and sometimes immunotherapy. Risk factors, such as smoking, occupational exposure, and chronic bladder infections, must be considered for risk assessment and prevention strategies.